— Know what they know.
Not Investment Advice

ARVN NASDAQ

Arvinas, Inc.
1W: -3.4% 1M: -14.4% 3M: -24.1% YTD: -20.7% 1Y: +37.0% 3Y: -61.0% 5Y: -86.4%
$9.09
-0.01 (-0.11%)
 
Weekly Expected Move ±6.0%
$8 $9 $9 $10 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 29 · $586.5M mcap · 56M float · 1.65% daily turnover · Short 38% of daily vol

📊 Key Metrics

TTM
$89M
Revenue
-79.1% YoY
$-221M
Net Income
-374.9% YoY
$-257M
Free Cash Flow
-1.6% YoY
92.9%
Gross Margin
-401.9%
Op. Margin
-369.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-44.5%
ROA-24.5%
ROIC81.2%

Valuation

P/E-2.6
P/B1.5
EV/EBITDA-0.0

Leverage

Debt/Equity0.02
Current Ratio4.92
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z-1.74
Beneish M-0.22

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms